NDAINJECTIONINJECTABLE
Approved
Apr 1947
Lifecycle
LOE Approaching
Competitive Pressure
30/100
Clinical Trials
2
Data completeness
2/8 — Basic
Drug data last refreshed Yesterday
AI summarySynthesized from FDA + DailyMed + ClinicalTrials.gov data
HYPROTIGEN 5% is an injectable protein hydrolysate indicated for sarcopenia, a condition characterized by age-related muscle loss and weakness. This nutritional therapeutic delivers essential amino acids via intravenous injection to support muscle protein synthesis and maintenance in patients with severe muscle wasting.
LOE Approaching
Legacy product approaching loss of exclusivity with minimal commercial infrastructure; roles likely focused on managed care defense and legacy brand maintenance rather than growth.
Mechanism of Action
Mechanism of action data is being enriched from DailyMed and FDA sources. Check back soon for updated drug intelligence.
Indications
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
Clinical Trials (2)
The Effects of MediDrink Platinum+ and Fava Bean Protein Hydrolysate on Fitness in an Aged Population
Started Sep 2025
75 enrolled
Sarcopenia in ElderlyMalnourishedProtein Supplementation+3 more
A Double-blind Randomized Controlled Trial of a Thickened Amino-acid-based Formula in Children Allergic to Cow's Milk and to Protein Hydrolysates
Started Mar 2011
86 enrolled
Cow Milk Allergy
Career Relevance
Zero linked job openings and legacy product status indicate limited career development on HYPROTIGEN 5%; opportunities exist primarily in defensive commercial roles managing reimbursement erosion, manufacturing optimization, and portfolio rationalization. This product represents a wind-down career assignment rather than a growth platform.
Worked on HYPROTIGEN 5% at B. Braun? Share your interview experience or compensation data (+7 days Pro)
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.